The feasibility and safety of high-intensity focused ultrasound combined with low-dose external beam radiotherapy as supplemental therapy for advanced prostate cancer following hormonal therapy

Asian Journal of Andrology

Volumn 13, Issue 3, 2011, Pages 499-504

  Wu, Rui Yi ^a   Wang, Guo Min ^a   Xu, Lei ^a   Zhang, Bo Heng ^a   Xu, Ye Qing ^a   Zeng, Zhao Chong ^a   Chen, Bing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

complication; high intensity focused ultrasound; hormonal therapy; low dose external beam radiotherapy; prostate cancer; survival rate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HIGH INTENSITY FOCUSED ULTRASOUND; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPH NODE; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; RADIATION DOSE; TOXICITY; UROGENITAL TRACT DISEASE; UROGENITAL TRACT TOXICITY;

AGED; COMBINED MODALITY THERAPY; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; ULTRASONIC THERAPY;

EID: 79955657798     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.153     Document Type: Article

References (25)

1. Sim HG, Cheng CW. Changing demography of prostate cancer in Asia. Eur J Cancer 2005; 41: 834-45. (Pubitemid 40467547)
2. Chang SS, Kibel AS. The role of systemic cytotoxic therapyfor prostate cancer. BJU Int 2009; 103: 8-17.
3. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch Het al. Metastaticpatternsof prostatecancer: anautopsystudyof 1,589patients. Hum Pathol 2000; 31: 578-83.
4. Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gyto 78 Gy. Int J Radiat Oncol Biol Phys 2005; 61: 1019-34. (Pubitemid 40340897)
5. Zietman AL, Coen JJ, Dallow KC, Shipley WU. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int J Radiat Oncol Biol Phys 1995; 32: 287-92.
6. Kennedy JE. High-intensityfocused ultrasound inthetreatmentof solidtumours. Nat Rev Cancer 2005; 5: 321-7.
7. Jernberg A, Edgren MR, Lewensohn R, Wiksell H, Brahme A. Cellular effects of high-intensity focused continuous wave ultrasound alone and in combination with X-rays. Int J Radiat Biol 2001; 77: 127-35. (Pubitemid 32096704)
8. Jun-Qun Z, Guo-Min W, Bo Y, Gong-Xian W, Shen-Xu H. Short-term resultsof 89cases of rectal carcinoma treated with high-intensity focused ultrasound and low-dose radiotherapy. Ultrasound Med Biol 2004; 30: 57-60. (Pubitemid 38201440)
9. Li M. Guidelines on diagnosis and treatment of prostate cancer. In: Na YQ, Sun G, editors. Chinese Guidelines on Diagnosis and Treatment of Urological Disease. Beijing: People's Medical Publishing House; 2009. p47.
10. Heidenreich A, Bolla M, Joniau S, van der Kwast TH, Matveev V et al. Guidelines on Prostate Cancer (Online). Arnhem: European Association of Urology; 2010. p91.
11. Theyer G, Hamilton G. Current status of intermittent androgen suppression in the treatment of prostate cancer. Urology 1998; 52: 353-9. (Pubitemid 28399897)
12. Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K et al. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation. J Urol 2008; 180: 915-9.
13. Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in thetreatmentof prostatecancer: asystematicreviewof theliterature. Eur Urol 2010; 57: 49-59.
14. Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM et al. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 2002; 95: 1028-36. (Pubitemid 34925353)
15. Pollack A, Smith LG,von Eschenbach AC External beam radiotherapydoseresponse characteristicsof 1127 men with prostate cancer in the PSAera. Int J Radiat Oncol Biol Phys 2000; 48: 507-12.
16. Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995; 55: 3346-51.
17. Chaussy C, Thüroff S. Resultsandsideeffectsof high-intensityfocused ultrasound in localized prostate cancer. J Endourol 2001; 15: 437-40. (Pubitemid 32467092)
18. Uchida T, Sanghvi NT, Gardner TA, Koch MO, Ishii D et al. Transrectal high-intensity focusedultrasoundfortreatmentof patientswithstageT1b- 2N0M0localizedprostate cancer: a preliminary report. Urology 2002; 59: 394-9.
19. Ficarra V, Antoniolli SZ, Novara G, Parisi A, Fracalanza Set al.Short-termoutcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostatecancer. BJU Int 2006; 98: 1193-8. (Pubitemid 44721223)
20. Kiel HJ, Wieland WF, Rössler W. Local control of prostatecancerbytransrectal HIFU-therapy. Arch Ital Urol Androl 2000; 72: 313-9.
21. Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L et al. Predictingthe riskof lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994; 28: 33-7. (Pubitemid 24012852)
22. Hu Z,Yang XY, Liu Y, Morse MA, Lyerly HKet al. Releaseof endogenousdangersignals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun 2005; 335: 124-31. (Pubitemid 41350771)
23. Rosberger DF, Coleman DJ, Silverman R, Woods S, Rondeau M et al. Immunomodulation in choroidal melanoma: reversal of inverted CD4/CD8 ratios following treatment with ultrasonic hyperthermia. Biotechnol Ther 1994; 5: 59-68.
24. Chaussy C, Thüroff S. High intensity focused ultrasound in prostate cancer: results after3years. Mol Urol 2000; 4: 179-82.
25. Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WFet al. Morbidityassociatedwith repeatedtransrectal high-intensityfocused ultrasoundtreatmentof localized prostate cancer. World J Urol 2006; 24: 585-90. (Pubitemid 44782312)